Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

New hair regrowth therapies show promise but need more research.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

m6A-circHECA may affect cashmere goat hair growth and is possibly controlled by gene promoter methylation.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

CXCL12+ fibroblasts help recruit neutrophils to fight skin infections.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Recognize Polish academic titles as proof of language proficiency for foreign-trained doctors.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Hair aging is caused by stress, hormones, inflammation, and DNA damage affecting hair growth and color.

Effective PCOS treatments require targeting specific signaling pathways.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Aortic aneurysm treatment has shifted to less invasive methods, improving safety and outcomes.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.